Literature DB >> 12356625

New efficient catheter-based system for myocardial gene delivery.

Ronen Beeri1, J Luis Guerrero, Gregory Supple, Suzanne Sullivan, Robert A Levine, Roger J Hajjar.   

Abstract

BACKGROUND: Manipulating gene expression in the failing heart has therapeutic promise, but until now efficient and homogeneous cardiac gene delivery has required an open-chest approach. This study examines the hypothesis that vector delivery promoted by echo contrast microbubbles will be maximized by injection of the vectors into the aortic root with brief balloon occlusion above the sinuses, while at the same time prolonging diastole and vasodilating with acetylcholine (ACh) to maximize coronary exposure. METHODS AND
RESULTS: After incubation with albumin-coated perfluorocarbon microbubbles, an adenovirus encoding a reporter gene was infused into the aortic root of rats. To maximize delivery, the aortic root was transiently occluded with a balloon catheter during a brief ACh-induced asystole. Ultrasound was used to image the delivery and disrupt the microbubbles. Aortic occlusion with concomitant ACh increased myocardial gene expression for virus + microbubbles by >2.5-fold, from 925+/-165 to 2358+/-376 relative units (RU; P<0.01). This delivery system also produced substantial expression with vector alone (1473+/-549 RU). All uptakes were significant compared with 433+/-332 RU without virus.
CONCLUSIONS: An adenoviral delivery system combining echo contrast with a catheter-based technique to maximize coronary perfusion increases gene delivery compared with echo contrast alone. This novel method permits efficient percutaneous gene delivery in closed-chest animals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12356625     DOI: 10.1161/01.cir.0000035240.92015.e4

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

1.  Myocardial gene and cell delivery.

Authors:  P D Lambiase; M S Marber
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

2.  Targeted endothelial gene delivery by ultrasonic destruction of magnetic microbubbles carrying lentiviral vectors.

Authors:  Hanna Mannell; Joachim Pircher; Thomas Räthel; Katharina Schilberg; Katrin Zimmermann; Alexander Pfeifer; Olga Mykhaylyk; Bernhard Gleich; Ulrich Pohl; Florian Krötz
Journal:  Pharm Res       Date:  2012-01-25       Impact factor: 4.200

Review 3.  Basic mechanisms of mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Jonathan Beaudoin; Mark D Handschumacher; Robert A Levine
Journal:  Can J Cardiol       Date:  2014-07-02       Impact factor: 5.223

Review 4.  Ultrasonic drug delivery--a general review.

Authors:  William G Pitt; Ghaleb A Husseini; Bryant J Staples
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

Review 5.  Cardiac gene therapy.

Authors:  Antoine H Chaanine; Jill Kalman; Roger J Hajjar
Journal:  Semin Thorac Cardiovasc Surg       Date:  2010

Review 6.  Cardiac gene therapy with SERCA2a: from bench to bedside.

Authors:  Judith K Gwathmey; Alexan I Yerevanian; Roger J Hajjar
Journal:  J Mol Cell Cardiol       Date:  2010-11-18       Impact factor: 5.000

Review 7.  Rescuing the failing heart by targeted gene transfer.

Authors:  Yoshiaki Kawase; Dennis Ladage; Roger J Hajjar
Journal:  J Am Coll Cardiol       Date:  2011-03-08       Impact factor: 24.094

Review 8.  Targeted gene therapy for the treatment of heart failure.

Authors:  Kleopatra Rapti; Antoine H Chaanine; Roger J Hajjar
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

9.  Potential of gene therapy as a treatment for heart failure.

Authors:  Roger J Hajjar
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

10.  Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.

Authors:  Adelaide Greco; Altomare Di Benedetto; Candace M Howard; Sarah Kelly; Rounak Nande; Yulia Dementieva; Michele Miranda; Arturo Brunetti; Marco Salvatore; Luigi Claudio; Devanand Sarkar; Paul Dent; David T Curiel; Paul B Fisher; Pier P Claudio
Journal:  Mol Ther       Date:  2009-11-03       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.